type 2 diabetes

GLP-1 drugs can cause weight loss, which results in an estimated 25% decline in musculoskeletal mass and increases the risk of fractures, especially for older adults. To mitigate this risk, patients should pair GLP-1 use with exercise and strength training while maintaining proper nutrition high in protein, calcium, vitamin D, and magnesium.

Rosie O'Donnell stated that she feels 'never better' at 64, crediting part of her improved health to Mounjaro, which was originally prescribed three years ago for diabetes management. She noted that she experienced unexpected weight loss and initially feared she had cancer after losing 12 pounds. The article also provides background information on Mounjaro (tirzepatide), noting it is a drug approved by the FDA for type 2 diabetes and chronic weight management.

The U.K. regulator has approved orforglipron for weight management and type 2 diabetes. This approval makes Britain the first country in Europe to clear the drug.

A new statement from the American Heart Association indicates that for most adults, moderate caffeine intake from coffee appears safe and may be linked to cardiovascular benefits. The group established a typical upper limit of 400 milligrams of caffeine per day as generally safe, while warning against high doses found in energy drinks. Furthermore, black caffeinated coffee was specifically linked to a lower risk of developing Type 2 diabetes.

Lilly's revenue increased by 48% due to strong demand for its GLP-1 drugs Mounjaro and Zepbound, which are used for treating Type 2 diabetes and weight loss.

The article states that the author prescribes diet changes weekly as a first-line treatment for type 2 diabetes, high blood pressure, and high cholesterol, which are prevalent conditions in American clinics. The author criticizes medical school for providing minimal relevant education on diet and nutrition.

A Dutch cohort study found that initiating antipsychotic medications, even for short durations, is associated with an increased prevalence of pharmacologically treated type 2 diabetes in youths. The study analyzed nearly 90,000 youths to establish this link.

England is experiencing a concerning rise in young women in their 20s developing Type 2 diabetes. The increase is described as 'worrying' in the article.

A new American Heart Association review suggests that up to 400 milligrams of caffeine daily, roughly three to five cups of coffee, is generally safe and may reduce risks of heart disease, stroke, and Type 2 diabetes. However, highly concentrated energy drinks and caffeine shots can increase blood pressure and cause irregular heart rhythms.

There has been a 70% increase in type 2 diabetes cases among Gen Z women, according to the article title. The surge is described as 'alarming' in the headline.

England is experiencing a worrying increase in women in their 20s developing type 2 diabetes, according to experts. The article highlights the need to recognize symptoms and risk factors associated with the condition.

A recent study suggests that not getting enough sleep increases the risk of weight gain, which is linked to conditions like heart disease and type 2 diabetes. The findings highlight a potential health consequence of mild sleep deprivation.

Consumer Reports found inorganic arsenic, a known carcinogen, in all 52 tested rice products. Brown rice and certain types like basmati and sushi rice vary in arsenic levels, with over 40% of products posing potential cancer and diabetes risks. Consumer Reports recommends reducing rice consumption, using alternative grains, and specific cooking methods to lower exposure.

A study found that adding a GLP-1 receptor agonist did not reduce the likelihood of veterans with type 2 diabetes discontinuing basal insulin therapy compared to other glucose-lowering agents. The findings suggest GLP-1s may not serve as an effective insulin off-ramp for this population.

A Louisiana-based study found that bariatric surgery for adolescents and young adults with severe obesity resulted in significant weight loss and health improvements. The research, conducted by LSU’s Pennington Biomedical Research Center, FMOL Health, and the Metamor Institute, showed 29%-32% average weight loss and remission of type 2 diabetes in 94% of patients, with low complication rates.

Scientists discovered that a modified Mediterranean-style diet low in protein and methionine improved health in mice by reducing body fat and frailty. Human data suggested lower animal protein intake correlates with reduced obesity and Type 2 diabetes rates.

Type 1 diabetes occurs when the pancreas stops producing insulin, requiring insulin treatment, while Type 2 diabetes involves insulin resistance and often responds to lifestyle changes or medications. The CDC reports 90-95% of diabetes cases are Type 2, with risk factors including being overweight. Early detection is critical as insulin resistance can precede diagnosis by years.

Type 1 diabetes occurs when the pancreas stops producing insulin, while Type 2 diabetes involves insulin resistance despite insulin production. The CDC reports 90-95% of diabetes cases are Type 2, often linked to overweight and lifestyle factors. Treatments differ, with Type 1 requiring insulin and Type 2 using medications or lifestyle changes.

A Medicare pilot program expands access to GLP-1 weight-loss medications like Wegovy and Zepbound for some seniors, offering subsidies as high as $50 per month. The program, running through 2027, requires a BMI above 35 or specific weight-related conditions for eligibility, though 6 million Medicare Part D recipients who might otherwise qualify will remain excluded. Concerns persist about potential bone and muscle density loss from rapid weight loss, but medical professionals suggest exercise can mitigate risks.

Millions of Americans can now get Medicare coverage for GLP-1 drugs to treat weight loss starting this week. Previously, Medicare only covered these drugs for conditions like Type 2 diabetes, sleep apnea, and stroke or heart-attack risk.

2-year results from the SUPPRESS-EARLY trial indicate that early use of tirzepatide (Mounjaro, Zepbound) in type 2 diabetes management significantly improves outcomes. The findings were presented at the American Diabetes Association annual meeting.

Vietnam veterans continue to battle health issues linked to Agent Orange exposure, with Art Gentry, a 77-year-old veteran, denied VA benefits due to his service at Subic Bay, which is not on the official presumptive exposure locations list. Despite prior approvals for similar claims, Gentry's case highlights the bureaucratic challenges veterans face in securing benefits for diseases like prostate cancer and Type 2 diabetes.

Vietnam veterans continue to fight for recognition of Agent Orange-related health issues, as seen in Art Gentry's denied VA benefits claim due to Subic Bay not being on the presumptive exposure list. The article highlights the bureaucratic challenges veterans face in proving exposure to the toxic herbicide.

A Penn State study found that environmental factors like air pollution can have a greater impact on disease risk than genetics. Researchers analyzed 50 million health records and linked pollutants such as particulate matter and nitrogen dioxide to increased risks of asthma, COPD, diabetes, and high cholesterol. The study emphasizes lifestyle changes, like eating more fruits/vegetables and monitoring air quality, to mitigate these risks.

A Penn State study found that environmental factors like air pollution can have a greater impact on disease risk than genetics. Researchers analyzed 50 million health records and linked pollutants such as particulate matter and nitrogen dioxide to increased risks of asthma, COPD, diabetes, and high cholesterol. The study emphasizes lifestyle changes like eating more fruits/vegetables and monitoring air quality to reduce health risks.

A review suggests that palmitic acid (found in meats, dairy, and palm oil) may increase type 2 diabetes risk by impairing insulin response, while oleic acid (found in olive oil, nuts, and eggs) may protect against insulin resistance. The study, led by the University of Barcelona and CIBERDEM, highlights that fat quality—not quantity—matters for diabetes risk, aligning with the benefits of the Mediterranean diet.

A new study suggests that semaglutide, the active ingredient in Ozempic and Wegovy, may strengthen bones in Type 2 diabetes patients by 15%. This effect was described as an unexpected side benefit of the weight loss drugs.

A federal judge ordered ICE to release a Palestinian leader of Wisconsin's largest mosque, citing a 'substantial' free speech claim after he criticized Israel. The man, a legal permanent resident, was detained for 80 days, with the government alleging he posed a foreign policy threat, but the judge found insufficient evidence to justify his detention.

A federal judge ordered ICE to release Salah Sarsour, president of Wisconsin’s largest mosque, after finding he raised a 'substantial' free speech claim for supporting Palestinian rights. Sarsour, a legal permanent resident detained for 80 days, was released following a ruling that ICE failed to justify his detention or address his medical needs, including unmonitored Type 2 diabetes.

A study found that diabetes patients using semaglutide (Ozempic, Wegovy) had a 15% lower risk of fractures compared to others with type 2 diabetes. The analysis reviewed medical records and focused on adults with the condition.

A large, real-world analysis found that adults with type 2 diabetes using GLP-1 receptor agonists had significantly lower risks of major diabetic foot complications compared to those using SGLT2 inhibitors. The study highlights differing risk profiles between the two medication classes for diabetic foot outcomes.

Salah Sarsour, a Palestinian U.S. permanent resident and president of Milwaukee’s Islamic Society, is detained in an Indiana facility where his lawyers claim his health is deteriorating due to inadequate diabetes care and he is denied religious freedoms. His attorneys argue his treatment violates the First Amendment and seek his release.

Attorneys for Salah Sarsour, a Palestinian-born legal permanent resident detained by ICE, claim he is denied consistent diabetes care in an Indiana jail, leading to a 30-pound weight loss and risks of organ failure. They also allege religious harassment and inadequate medical treatment for his condition.

Monotherapy with once-weekly retatrutide, an investigational triple hormone receptor agonist, improved glycemic control and body weight in adults with type 2 diabetes, as shown in the phase III TRANSCEND-T2D-1 trial. Up to 40% of patients achieved normal HbA1c levels.

Once-daily orforglipron improved outcomes in adults with type 2 diabetes and inadequate glycemic control, according to the ACHIEVE-5 trial. The drug is an add-on treatment for patients already on insulin glargine.

A new triple-action weekly jab for type 2 diabetes, retatrutide, showed significant reductions in blood sugar and body weight in phase 3 trials. Patients receiving retatrutide lost over four times more weight and experienced more than twice the drop in HbA1c compared to placebo. The drug mimics three gut hormones (GLP-1, GIP, and glucagon) and differs from existing diabetes medications by engaging the glucagon receptor to increase energy expenditure.

Scientists have identified genetic variants that may reduce the effectiveness of GLP-1 drugs for treating Type 2 diabetes in about 10% of the population. These variants appear to cause 'GLP-1 resistance,' making carriers less likely to achieve healthy blood sugar targets during clinical trials of these medications.

Research indicates that the timing of puberty in girls is linked to long-term health risks. Early puberty is associated with higher risks of diseases like diabetes, heart disease, and breast cancer, while late puberty correlates with conditions such as celiac disease and asthma. Both early and late puberty are connected to early menopause, which carries additional health risks.

A daily tablet may revolutionize type 2 diabetes treatment according to a trial. The findings suggest the medication could significantly improve management of the condition.

Top ultra-processed food researchers advocate for policy changes, citing bipartisan public concern over health risks like obesity and diabetes. A survey shows majority support for government interventions such as testing additives for safety, banning artificial dyes, and reducing sugar and salt in foods.